Synonyms:Framycetin, neomycin, NEOMYCIN B, Fradiomycin, Mycifradin, Soframycin, 119-04-0, Fradiomycin B, Actiline, Enterfram, Framygen, Actilin, Neomas, Fradiomycinum, Framicetina, Framycetine, Framycetinum, Caswell No. 595, Nivemycin, Neomycin B sulfate, Antibiotic 10676, NEOMYCIN SULFATE, 1404-04-2, Neobrettin, USAF CB-19, CCRIS 5462, Framidal, Framycin, Francetin, Dekamycin iii, HSDB 3242, Soframycine, Framycetin (INN), Neo-Rx, Antibiotique, Myacyne, Neolate, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy-3-hydroxycyclohexyl]oxyoxane-3,4-diol, ANTIBIOTIQUE EF 185, Neomycin sulphate, CHEBI:7508, Vonamycin powder V, Neomcin, Neomin, 4BOC774388, Neomicina [DCIT], Framycetinum [INN-Latin], Neomicina, Neomycine, Neomycinum, PIMAVECORT, FRAMYCETIN [INN], Neomycine [INN-French], Neomycinum [INN-Latin], (1R,2R,3S,4R,6S)-4,6-diamino-2-{[3-O-(2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl)-beta-D-ribofuranosyl]oxy}-3-hydroxycyclohexyl 2,6-diamino-2,6-dideoxy-alpha-D-glucopyranoside, Framycetine [INN-French], NMY, Framicetina [INN-Spanish], Framycetin [INN:BAN:DCF], Bycomycin, Jernadex, (2S,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(2R,3S,4R,5S)-5-{[(1R,2R,3S,5R,6S)-3,5-diamino-2-{[(2R,3R,4R,5S,6R)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-6-hydroxycyclohexyl]oxy}-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]oxy}oxane-3,4-diol, Fradiomycin B;Neomycin B, Neomycin [INN:BAN], EINECS 204-292-2, EINECS 215-766-3, EPA Pesticide Chemical Code 006303, BRN 0101621, Mycerin, UNII-I16QD7X297, UNII-4BOC774388, Antibiotic 956, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-2-[(2S,3R,4S,5R)-4-[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxy-tetrahydropyran-2-yl]oxy-3-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]oxy-3-hydroxy-cyclohexoxy]tetrahydropyran-3,4-diol, NEOMYCINB, Antibiotic produced by Streptomyces decaris. Neomycin B, NEOMYCIN B [MI], Prestwick3_000158, KDR Kinase Inhibitor, 3, BDBM19, Neomycin B; Fradiomycin B, SCHEMBL3279, FRAMYCETIN [WHO-DD], BSPBio_000296, GTPL709, NEOMYCIN B [USP-RS], 4-18-00-07476 (Beilstein Handbook Reference), D-Streptamine, O-2,6-diamino-2,6-dideoxy-alpha-D-glucopyranosyl-(1-4)-O-(O-2,6-diamino-2,6-dideoxy-beta-L-idopyranosyl-(1-3)-beta-D-ribofuranosyl-(1-5))-2-deoxy-, BPBio1_000326, CHEMBL184618, DTXSID2023359, HMS2089P15, I16QD7X297, AKOS024284361, CS-6390, DB00452, NCGC00179612-01, D-Streptamine, O-2,6-diamino-2,6-dideoxy-.beta.-L-idopyranosyl-(1.->3)-O-.beta.-D-ribofuranosyl-(1->5)]-O-[2,6-diamino-2,6-dideoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy, HY-17624, AB00443887, C01737, D05140, AB00443887-03, EN300-7480789, MYCIFRADIN; NEOMAS; PIMAVECORT; VONAMYCIN, ANTIBIOTIC PRODUCED BY STREPTOMYCES DECARIS, J-004060, Q4492348, BRD-K71013094-065-01-2, (2R,3S,4R,5R,6R)-5-amino-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-2-{[(2S,3R,4S,5R)-4-{[(2R,3R,4R,5S,6S)-3-amino-6-(aminomethyl)-4,5-dihydroxyoxan-2-yl]oxy}-3-hydroxy-5-(hydroxymethyl)oxolan-2-yl]oxy}-3-hydroxycyclohexyl]oxy}oxane-3,4-diol, 11004-65-2, 6-(2-{(4S,2R,3R,5R)-4-[(5S,6S,2R,3R,4R)-3-amino-6-(aminomethyl)-4,5-dihydroxy( 2H-3,4,5,6-tetrahydropyran-2-yloxy)]-3-hydroxy-5-(hydroxymethyl)oxolan-2-yloxy }(3S,6S,1R,2R,4R)-4,6-diamino-3-hydroxycyclohexyloxy)(3S,2R,4R,5R,6R)-5-amino- 2-(aminomethyl)-2H, D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4)-O-(O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-.BETA.-D-RIBOFURANOSYL-(1->5))-2-DEOXY-, D-STREPTAMINE, O-2,6-DIAMINO-2,6-DIDEOXY-.BETA.-L-IDOPYRANOSYL-(1->3)-O-.BETA.-D-RIBOFURANOSYL-(1->5)-O-(2,6-DIAMINO-2,6-DIDEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-, WURCS=2.0/3,3,2/[a222h-1b_1-4][a2122h-1a_1-5_2*N_6*N][a2121h-1b_1-5_2*N_6*N]/1-2-3/a1n2-b1n1*1OC^RC^RO*2/4C^SC^RCC^S$3/10N/8N/7O_a3-c1
Pubchem:PUBCHEM:8378
Id:f355e962-a4cd-56e3-8778-016c5ed8955d
Description:nan
